CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: BIO 2016 (619) Smart Money VCs (6326)
Aradigm is an emerging specialty pharmaceutical company developing and commercializing a portfolio of drugs delivered by inhalation for the treatment of severe respiratory disease. Bolstered by its depth of expertise in pulmonary drug delivery and an...Show all
Company (IPO / Went public)
Phone: 510-265-9000
3929 Point Eden Way
Hayward, 94545
California, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Aradigm Corporation | $11.5M | Dec 23, 2004 |
| Minrad | $57.2M | May 7, 2008 |
| PercuSurge | $58.2M | Dec 21, 2000 |
| See all 32 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Concentrated, inhalable ciprofloxacin formulation | Oct 20, 2016 | Sep 24, 2019 | Patent |
| Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria | Nov 22, 2017 | Aug 13, 2019 | Patent |
| Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile | Oct 03, 2014 | Jun 05, 2018 | Patent |
| Novel liposomal formulations that form drug nanocrystals after freeze-thaw | Feb 11, 2015 | May 15, 2018 | Patent |
| Diagnosis of entry of gastrointestinal contents into respiratory tract of humans and animals | Feb 18, 2015 | Jan 02, 2018 | Patent |
